Nicotinic acetylcholine receptors in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 1, Issue 4-5, 1999, Pages 207-219

  Wevers, A ^a   Schroder, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE; 3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 4 [[2 (1 METHYL 2 PYRROLIDINYL)ETHYL]THIO]PHENOL; ALPHA BUNGAROTOXIN; CYTISINE; EPIBATIDINE; LIGAND; LOPHOTOXIN; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; TAU PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BINDING SITE; COGNITIVE DEFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW;

EID: 0033302309     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-14-503     Document Type: Review

References (86)

1. Diversity of interacting receptors
2. Nicotinic Receptor Function in the mammalian central nervous system
3. Nucleotide sequence of the human nicotinic acetylcholine receptor β2 subunit gene
4. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer'S disease
5. Comparative alterations of nicotinic and muscarinic sites in Alzheimer'S and Parkinson'S diseases
6. The effects of nicotine on brain neurotransmitter systems
7. Receptor classes and the transmitter-Gated ion channels
8. The cholinergic hypothesis of geriatric memory dysfunction
9. Ligand-Gated ion channels in the brain, The amino-Acid receptor superfamily
10. Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-Alpha-Bungarotoxin binding in human postmortem brain
11. Expression of cerebrocortical nicotinic acetylcholine receptors in neurodegenerative diseases: Quantitative studies
12. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes
13. 5-Nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines
14. Nicotinic receptors and cholinergic neurotransmission in the central nervous system
15. Binding sites for neurotoxins and cholinergic ligands in peripheral and neuronal nicotinic receptors. Studies with synthetic receptor sequences
16. Age associated decline in high affinity nicotine binding in human brain frontal cortex does not correlate with the changes in choline acetyltransferase activity
17. Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes
18. Postmortem stability of α-bungarotoxin binding sites in mouse and human brain
19. Changes in nicotinic receptors in human and rat CNS
20. Cloning and sequence of the human α7 nicotinic acetylcholine receptor
21. Comparative structure of human neuronal α2-α7 and β2-β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2 and β4 subunits
22. A monoclonal antibody interfering with binding and response of the acetylcholine receptor
23. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment
24. 3H]nicotine binding in human cerebral cortex, Comparison between Alzheimer'S disease and the normal
25. Molecular cloning of human neuronal nicotinic receptor α3-subunit
26. The cholinergic system in Alzheimer'S disease
27. Cholinergic receptors in human brain, effects of aging and Alzheimer'S disease
28. Cholinesterase inhibitors for Alzheimer disease therapy: Past, present and future
29. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain
30. Immunocytochemical localization of a neuronal nicotinic receptor: The β2-subunit
31. Muscarinic and nicotinic cholinergic binding sites in Alzheimer'S disease cerebral cortex
32. Alzheimer'S drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist
33. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity
34. Expression of α4 and α7 nicotinic receptor subunits in parvalbumin-immunoreactive interneurons in the human temporal cortex
35. Neurotransmitter receptor mapping by autoradiography and other methods
36. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer type patients
37. Probing ion channels and recognition sites of neuronal nicotinic cholinergic receptors with novel nicotine affinity and other ligands
38. Neuronal nicotinic receptor subtypes
39. Development of nicotinic agonists for the treatment of Alzheimer'S disease
40. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents
41. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer'S dementia
42. Diversity and patterns of regulation of nicotinic receptor subtypes
43. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors
44. Modulatory control by non-competitive agonists of nicotinic cholinergic transmission in the central nervous system
45. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation
46. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine
47. Cloning and transient expression of genes encoding the human α4 and β2 neuronal nicotinic acetylcholine receptor (nAChR) subunits
48. The role of nicotinic systems in the cognitive disorder of Alzheimer'S disease
49. Nicotinic system involvement in Alzheimer'S and Parkinson'S disease. Implications for therapeutics
50. Neuroreceptor changes in Alzheimer disease
51. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains
52. Cholinesterase inhibitors - Are they all the same?
53. Human α7 acetylcholine receptor: Cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptor and fucntional α7 homomers expressed in Xenopus oocytes
54. Increased nicotinic receptors in brains from smokers: Membrane binding and autoradiography studies
55. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer'S disease
56. A postmortem study of brain nicotinic receptors in Parkinson'S and Alzheimer'S disease
57. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels
58. Current concepts on the effects of nicotine on neurotransmitter release in the central nervous system
59. The diversity of neuronal acetylcholine receptors
60. Immunohistochemistry of cholinergic receptors
61. Cellular and subcellular distribution of receptors in the entorhinal-hippocampal system: Morphologic and biochemical aspects
62. Immunhisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man
63. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer'S disease
64. Molecular cloni functional properties and distribution of rat brain alpha 7. A nicotinic cation channel highly permeable to calcium
65. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia
66. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-) nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography
67. Nicotinic acetylcholine receptor subtypes in human frontal cortex changes in Alzheimer'S disease
68. Nicotinic receptor agonists increase acetylcholine and norepinephrine levels in rat cortex: A microdialysis study
69. Noranhydroecgonine increases cortical release of biogenic amines and decreases release of cortical serotonin in rats
70. Neuronal-type nicotinic receptors in human neuroblastoma and small-cell lung carcinoma cell lines
71. Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer'S disease
72. Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus
73. 4-[[2-(1-Methyl-2-pyrrolidinyl) ethyl]thiophenol hydrochloride (SIB-1553A): A novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors
74. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors
75. Expression and characterization of the rat alpha 4 beta 2 neuronal nicotinic cholinergic receptor in baculovirus-infected insect cells
76. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains
77. Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization
78. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer'S disease - Histotopographical correlation with amyloid plaques and hyperphosphorylated tau-protein
79. Nicotinic receptors in Alzheimer'S disease - From autopsy studies to organotypic culture models
80. Cellular distribution of the mRNA for the α7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex - A non-isotopic in situ hybridization study
81. Nicotinic acetylcholine binding sites in Alzheimer'S disease
82. Reductions in acetylcholine and nicotinic binding in several degenerative diseases
83. 3H]nicotinic acetylcholine binding in Alzheimer'S disease and Parkinson'S disease: An autoradiographic study
84. Molecular cloning of a human neuronal nicotinic acetylcholine receptor α3-like subunit
85. Presynaptic nicotinic ACh receptors